stockrowCollegium Pharmaceutical, Inc. (COLL) vs Cronos Group Inc. (CRON)
- Collegium Pharmaceutical, Inc. COLL 24.27 −3.54%
- Cronos Group Inc. CRON 3.62 −2.69%
Collegium Pharmaceutical, Inc. and Cronos Group Inc. are both Drug Manufacturers Specialty & Generic companies. Cronos Group Inc. is the larger, with a market value of $1.4B against $819.1M — 1.7× the size. Collegium Pharmaceutical, Inc. trades at the lower P/E: 20.0× against 21.3×. Cronos Group Inc. grew revenue faster over the last twelve months: 55.8% against 7.68%. Cronos Group Inc. has the higher net margin (28.0% vs 4.68%) and the lower return on invested capital (1.28% vs 6.29%). Across the 21 metrics below, Collegium Pharmaceutical, Inc. leads on 13 and Cronos Group Inc. on 8.
Valuation
Profitability
| Metric | COLL | CRON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 59.05% | 46.59% | 53.51% |
| Operating margin | 15.22% | 3.78% | 0.00% |
| Net margin | 4.68% | 28.04% | (2.31%) |
| Free cash flow margin | 41.25% | 31.71% | 0.00% |
| Return on equity | 13.36% | 5.12% | (0.80%) |
| Return on assets | 2.06% | 4.87% | (1.67%) |
| Return on invested capital | 6.29% | 1.28% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack